supp.fit
All study protocols

Agmatine: study protocols

5 study groups say how much Agmatine participants took a day. These are the doses the studies gave. They are not a recommendation.

Agmatine: what the research found →

Dose per serving from research

5 study groups in 1 study say how much Agmatine participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 2.5 g to 5 g, 80% of 5 study groups.

Daily doseStudy groups
1 g to 2.5 g
1
2.5 g to 5 g
4

Commonly used together

None of these 5 study groups took Agmatine with anything else.

5 study groups

Study
Safety and Efficacy of Dietary Agmatine Sulfate in Lumbar Disc-associated Radiculopathy. An Open-label, Dose-escalating Study Followed by a Randomized, Double-blind, Placebo-controlled Trial
2010 · Agmatine group · Participants diagnosed with herniated lumbar disc-associated radiculopathy; age and sex details not provided in the abstract
2.67 g2 weeks51
Safety and Efficacy of Dietary Agmatine Sulfate in Lumbar Disc-associated Radiculopathy. An Open-label, Dose-escalating Study Followed by a Randomized, Double-blind, Placebo-controlled Trial
2010 · 1.335 g/day agmatine sulfate cohort · Participants in the open-label dose-escalation study; age, sex and condition details not provided in the abstract
1.34 g10 days—
Safety and Efficacy of Dietary Agmatine Sulfate in Lumbar Disc-associated Radiculopathy. An Open-label, Dose-escalating Study Followed by a Randomized, Double-blind, Placebo-controlled Trial
2010 · 2.670 g/day agmatine sulfate cohort · Participants in the open-label dose-escalation study; age, sex and condition details not provided in the abstract
2.67 g10 days—
Safety and Efficacy of Dietary Agmatine Sulfate in Lumbar Disc-associated Radiculopathy. An Open-label, Dose-escalating Study Followed by a Randomized, Double-blind, Placebo-controlled Trial
2010 · 3.560 g/day agmatine sulfate cohort, 10 days · Participants in the open-label dose-escalation study; age, sex and condition details not provided in the abstract
3.56 g10 days—
Safety and Efficacy of Dietary Agmatine Sulfate in Lumbar Disc-associated Radiculopathy. An Open-label, Dose-escalating Study Followed by a Randomized, Double-blind, Placebo-controlled Trial
2010 · 3.560 g/day agmatine sulfate cohort, 21 days · Participants in the open-label dose-escalation study; age, sex and condition details not provided in the abstract
3.56 g3 weeks—